Fremanezumab-Vfrm
3 NDCs across 1 manufacturer|0 Generic,3 Brand
▸ More about this market▾ Less
In 2024, Medicare Part D spent $103 million on Fremanezumab-Vfrm across 116,000 claims for 24,000 beneficiaries.
Fremanezumab-Vfrm is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $507.43 to $508.59 per ML — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$507.43 – $508.59
per ML
7d Activity
avg -0.1% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing FREMANEZUMAB-VFRM
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
AJOVY 225 MG/1.5 ML SYRINGE | $508.5851 per ML | 0.00% |
AJOVY 225 MG/1.5 ML AUTOINJECT | $508.1501 per ML | -0.01% |
AJOVY 225 MG/1.5 ML AUTOINJECTOR (3 PACK) | $507.4253 per ML | -0.18% |
Frequently Asked Questions
How much does Medicare spend on Fremanezumab-Vfrm?
In 2024, Medicare Part D spent $103 million on Fremanezumab-Vfrm across 116,000 claims for 24,000 beneficiaries.
How many Fremanezumab-Vfrm products are on the market?
The Fremanezumab-Vfrm drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Fremanezumab-Vfrm?
NADAC reference prices for Fremanezumab-Vfrm range from $507.4253 to $508.5851 per ML — a 0% difference between cheapest and most expensive.
Which manufacturers make Fremanezumab-Vfrm?
1 manufacturer lists Fremanezumab-Vfrm in NADAC. Ranked by number of NDCs, the largest are Teva Pharmaceuticals USA Inc. (3).
How has the price of Fremanezumab-Vfrm changed recently?
Over the past 7 days, 0 Fremanezumab-Vfrm NDCs rose and 2 fell, with a market-wide average change of -0.1%.